Objectives To explore the factors that influence career progress for early stage clinician-scientists and to identify ways to mitigate these factors in the context of emerging Asian academic medical centres (AMCs). Design Qualitative interviews and thematic data analysis based on grounded theory. setting and participants Five focus group interviews comprising 29 early career clinician-scientists who have received their first national-level career development award in Singapore. results Clinical priorities represented an overarching concern with many reporting the difficulty in delineating responsibilities between clinical care and research. Additionally, there was a prevailing perception of the lack of support for research at the institutional level. Participants tended to identify mentors through their own efforts in a relatively haphazard manner, often owing to the dearth of role models and perceived inadequacy of reward systems for mentoring. Support from mentors was thought to be limited in terms of targeted scientific guidance and long-term commitments to the relationship. Most of the participants expressed concerns about how they could secure the next level of funding with diminishing confidence. Notably, the work-life balance was neither conceptualised as a 'barrier' to successful pursuit of research career nor was it translated into the reason for leaving the dual clinical-research career pathway. Conclusions Results revealed specific limitations presented by the research environment in newly emerging Asian AMCs. To retain a vibrant clinician-scientist workforce, additional measures are needed, aiming to improve institutional culture of research, build mentoring networks, adopt effective tools for tracking career progress and provide a clear and viable career progression path for clinician-scientist. Further research might explore the cross-cultural differences in managing work-life balance in academic medicine.
IntrODuCtIOn
Early career clinician-scientists in academic medicine are the innovators of the future. They bring fresh ideas and technologies to existing clinical research and pioneer new areas of investigation.
1 2 Despite the important role played by aspiring young clinician-scientists in academic medicine, concerns have been raised over the past decades, particularly in North America, about the failure to retain motivated early career clinician-scientists in medical institutions to continue their pursuit in research. Narratives such as 'endangered species' 3 and 'leaky pipeline' 4 have invariably portrayed the increasingly challenging conditions placed on the survival of early career clinician-scientists and consequently, the sustainability of academic medicine. 5 A growing body of research indicates that clinician-scientists encounter a range of significant challenges that hamper their career progress in research. While failure to obtain independent funding contributes significantly to attrition from the career path for early stage investigators, 6 7 other issues beyond funding have been also noted. They include pressure on clinicians to increase clinical productivity, inadequate resources strengths and limitations of this study ► This is the first national study that comprehensively examined the current experiences and perceptions of clinician-scientists towards pursuing a research career in Asia. ► There is a dearth of studies for early stage clinicianscientists in non-North American academic medical centres. ► The qualitative method allowed for more nuanced accounts of the career transition for early stage clinician-scientists. ► We limited our participants to practicing clinicians with rising research interest for a given career path and therefore our results may not be applicable to individuals with non-clinical background seeking careers in academic medicine. ► We are unable to claim that results from this study based on a single country study are wholly generalisable to other emerging Asian academic medical settings.
Open Access to protect research time, difficulty covering loans with low salary, unsupportive environment and inadequate accessibility of research infrastructure such as database, biological archives and capability of computing facilities. Lack of mentorship and role models, as well as personal factors, are thought to have contributed to the barriers to successful transition of new investigators to independence. [8] [9] [10] [11] [12] [13] [14] While the existing literature provided important knowledge about the barriers faced by clinician-scientists, studies often included a whole spectrum of clinician-scientists from early to advanced careers, rather than focusing on more homogenous groups in terms of career progress. Additionally, the existing literature is primarily characterised by a large volume of non-empirical publications (eg, opinion pieces, letters and commentaries) based on anecdotal cases and not well substantiated by evidence that has been collected systematically. Furthermore, studies that have used a quantitative method tend to focus on career satisfaction and outcomes of career development programmes, 9 15 16 whereas qualitative studies typically provide descriptions of one or more specific components of career progression, such as mentoring, work-life balance and resilience. [17] [18] [19] [20] [21] [22] One study conducted by Robinson and colleagues provided a comprehensive range of factors that facilitated career success for career development awardees in the United States. 8 However, there is a dearth of studies for early stage clinician-scientists in non-North American academic medical centres (AMCs). In particular, no research so far has been undertaken on the experience of early career clinician-scientists in the context of newly emerging Asian academic medical settings.
We aimed to fill this gap by generating an in-depth understanding of the career transition for early stage clinician-scientists in emerging Asian AMCs. Specifically, this study sought to explore the nature of experience and barriers to career progression perceived by clinician-scientists who have received the first national-level career development award in Singapore. An understanding of the limitations presented by the current research environment in academic medicine will provide an insight into how best to overcome these barriers. Importantly, this study may inform future efforts to establish a stable pipeline that nurtures clinician-scientists in other newly emerging AMCs.
For this study, clinician-scientists are defined as clinicians practicing in Singapore, who have received the first national-level career development award that provides both salary and research funding to do research in their respective institutions.
MethODs setting: career development award in singapore In Singapore, despite the government's emphasis on biomedical sector as a key engine of economic growth, the number of clinician-scientists has generally remained low. 23 In order to build a cadre of clinician-scientists, the National Medical Research Council (NMRC), the primary funder of biomedical research and training in Singapore, initiated a competitive research career award, named the Transition Award (T-award), in 2012. This mentored award programme aims to assist the career development of early stage clinician-scientists by providing 3 years of salary support and a research grant for a specific project. The T-award stipulates that applicants must have received at least 2 years of intensive research experience in relevant local or overseas universities, research institutes and centres. Further, they must be at the early stage of their research careers in not having received any substantial competitive research funding defined by a specific quantum. The T-award is given primarily to an individual who holds a clinical qualification (MBBS, MD, MDS or equivalent) and registered in Singapore Medical Council's register of specialists. However, the following two categories of applicants are considered as exception on a case-by-case basis: (1) non-medically trained and PhD holders working in human clinical research (eg, PhDs in areas of biostatistics, epidemiology, behavioural science, nursing, pharmacy, psychology and allied health); (2) individuals who demonstrate completion of specialist training in foreign countries and are not registered and working as specialists in Singapore. 24 Between 2012 and 2016, the T-award programme produced 46 awardees from different clinical specialty areas, and 10 individuals received the T-award as 'exception cases'. In parallel, the development of two AMCs in Singapore has further provided clinician-scientists with an environment conducive to pursing excellence in clinical academic medicine. [25] [26] [27] Data collection From the list of 46 recipients awarded between 2012 and 2016, we excluded 10 awardees who received the T-award as 'exception cases' and one who had not commenced work on his T-award at the time of the study. We excluded these individuals for the following reasons: first, 'exception cases' who are non-medical scientists doing clinical research do not face multiple competing demands at work that the clinician-scientists face as the latter have a career combining clinical work with concurrent research. Therefore, the perspectives of these 'exception cases', including the factors influencing their career progression, may be different from those of the clinician-scientists. Second, recipients as 'exception cases' are generally better trained than their clinician-scientist counterparts in research, as more from this group have MSc or PhD in research compared with the clinician-scientists. Finally, we excluded the awardee who had not commenced work on his award as he would not have experienced the challenges encountered by early stage clinician-scientists in working on their T-award research projects.
We purposively approached 35 eligible T-award recipients via email and 29 individuals took part in one of the five focus groups, each involving three to seven participants. Reasons for refusal by six eligible recipients included not being available or interested (figure 1). In order to ensure a degree of commonality and shared experience among participants in each group, the focus groups consisted of participants from the same host institution. We developed an interview guide with openended questions to solicit the participants' experience and perceptions of the clinician-scientist career path. Between June and July 2016, the first author, who has extensive experience in qualitative research, conducted focus group interviews in a conference room. In Singapore, English is the first language and hence all interviews were conducted in English. Each focus group lasted approximately 75-90 min and were audio-recorded. We differentiated speakers by giving each participant a numeric identifier in the focus groups. We achieved data saturation 28 after four focus group interviews. All participants gave informed consent.
Data analysis
We transcribed the interviews verbatim and analysed the transcripts thematically based on a grounded theory approach. 29 In the first step, the first author (SY) and her assistant, who was a trained qualitative researcher, independently identified themes using a constant comparative method in a subset of transcripts and developed codes from these themes. This process allowed themes and explanations to arise inductively from the data. In the second step, all authors (SY, WPK, MEHO and JT) had consecutive rounds of iterative discussion, through which any discrepancies in interpretation were reconsidered in order to reach an agreement. This allowed for intercoder clarification of themes and coding, thus enhancing validity and reliability. We compiled a further classification, in which several codes and categories were refined and recoded. Alternative interpretations were also incorporated into the analysis. In the third step, the first author (SY) drew up a summary of themes with verbatim quotes aimed at exemplifying the codes and categories. Using the QSR NVivo 11 software, we retrieved quotes associated with each theme to determine the difference by participants' characteristics (eg, gender) and reliability of categories. To ensure the rigour of the study, we anchored our methodology according to the Consolidated Criteria for Reporting Qualitative Research (COREQ) checklist. 30 results Among 29 participants, 18 (62%) were men and 17 (58%) were at the rank of a consultant or the equivalent when they received the T-award. The mean age at the time of award was 39 years, with 28% at ages over 40 years. Approximately half of the participants (14/29, 48%) had obtained research training fellowship from the NMRC to pursue training in research prior to receiving the T-award (table 1) .
We identified several recurring and prominent themes with regard to the factors influencing career development perceived by early stage clinician-scientists. A key theme that emerged was that despite being positive about embarking on a research career, many participants found it challenging to pursue the research career path they wanted. Factors influencing research career development essentially related to the research role and support in multiple realms.
Coping with clinical priorities
On the whole, although participants recognised that having protected time for research was pivotal to career success, many experienced difficulty maintaining research activity. As shown in table 1, nearly two-thirds of the participants dedicated less than 60% of their time Open Access to research. A myriad of conflicting demands appeared to have impeded balancing clinical duties and research activities. When asked about conflicting demands, many pointed out the perceived pressure to perform clinical duties and frequent intrusions owing to the overwhelming volume of patient encounters and on-call duties. Other competing demands include being assigned to administrative leadership roles in the department, teaching obligations and concerns about losing clinical competency, particularly for those working in surgical specialties. The following quotes illustrate that many things eroded into the protected time:
Even though on paper I'm only meant to be doing 30% [of clinical work], on the ground within my department, there is a requirement or a need because essentially no one backfills, no one comes in to take over your job. So there's still work that needs to be done (Participant 13).
Because I am doing research, I was appointed as the research director of my department. Half of my time is spent on sorting out the problems that are inherent in the department and the institution (Participant 2). Therefore, longer work hours were unavoidable in order to meet the demands and expectations of both clinical and research work. By and large, there was a common perception that research was not adequately valued by the medical institutions, and the insufficient protected time was attributable to the organisational emphasis on clinical work over research activities.
The main issue is that clinical work is always number one in the current institution I'm at. So research is always look upon as a life of leisure or something extra. At the end of the day, if you have to drop something, research always gets dropped first. (Participant 22) The low institutional support for research also hampered the manpower backfill process. Although funding was made available to cover T-awardees' research time, clinical replacement rarely took place, at times resulting in conflict with and resentment from other clinicians. Consequently, participants often found themselves in a situation where peer clinical colleagues viewed their time spent on research as 'time off'. As one participant noted:
For example, my colleague said 'Oh okay, we need to cut down your clinic now in order to give you protected time? So I have to ask somebody else to take over your clinic?' Begrudgingly then, that person does it, and then now people are not happy with me. (Participant 1) The clinical priorities also appeared to have a considerable ramification for career advancement. Participants commonly felt that current metrics for promotion was unfair to clinician-scientists and the reason for some to eventually give up research. The expectation to do well both as a clinician and a scientist under the existing promotion metrics generated an overall sense of frustration in pursuing a research career. As the following participants stated:
It startled me to realize fairly recently that to move on and become a senior consultant, I may be held back. It impedes career transition because I'm not compared to other clinician scientists. I'm compared to other straight scientists or straight clinicians. Actually, I'm compared to both, and I can never compete with either of those. That's a big challenge.
(Participant 8)
It is a de facto agreement right now that if you are an almost full time research clinician, you can't possibly be promoted equally on the same track. That already puts you at a big disadvantage. There seems to be no hurry to try and crack that, which is going to be detrimental in the long run because I can see that my junior colleagues have a lot of reluctance to take up academic careers. (Participant 12) Participants commonly mentioned that multiple types of mentors were required to serve various needs that ranged from knowledge-specific guidance to career advice.
The mentor serves a few purposes, and you may need different mentors beyond the primary mentor for that grant, because different supervisors and mentors have different strengths and skill sets. (Participant 11)
Many participants actively looked for international mentors. By and large, while scientific guidance from international mentors was seen helpful, some participants felt concerned about the potential for competition with their international mentors in the long run.
If you are building cohort and there is nobody guiding you on how to look at the disease in particular, that is the problem. With the mentor overseas, they can still give you some of the advice, but some of the time, you are the competitor. You have to be careful about which overseas mentors you will be approaching because they will end up being your competitors.
(Participant 28)
Recurring annotations from the participants were that locally, there were not enough mentors who could guide them in their content-specific research projects. While many saw the absence of local expertise as a crucial concern, a small group of participants asserted that the underlying reason for insufficient mentors was the absence of mentor-matching system for junior researchers to identify suitable mentors. Additionally, it was generally perceived that there was inadequate academic reward to incentivise mentors to devote the time to develop effective mentorship relationships.
I had applied for T-award three times before I got it. So people asked me why I failed so many times. In my clinical specialty, nobody does research. So the difficulty is you can't find mentors in the same specialty. It's impossible because no one else has gone through the same path. So it's totally unchartered.
(Participant 17)
There's the kind of culture that taking on someone as a mentee is extra work for which they don't get recognized and there's no value added for them to bother. Or people in my discipline don't have that kind of belief that they need to nurture the next generation of clinician-researchers…The only time I met my mentors is when I applied for my T-award. Since I received the T-award, I have been moving on without mentors. (Participant 6) There was also a lack of network of collaborators and research resources for the T-award recipients, with Open Access resultant negative impact on research productivity. For example, having to work alone restricted access to an integrated array of manpower, research facilities, databases and even a dedicated office space for research. As one participant described: I lost one research staff. He is a research pathologist with a unique set of skills that I cannot easily find, and I waited for half a year for another candidate to appear. That Managing transition: sense of insecurity in future career path One important theme in this study was the prevailing perceptions of career uncertainty. While many had motivation and aptitude for research, they were often discouraged by the lack of clarity on routes to further their research career. Participants noted that planning a research career path was straightforward in the early stage when they embarked on applying for the T-award. However, due to low success rate in the acquisition of independent funding after the T-award, participants began to lose confidence in their ability to secure further research funding. The apparent lack of confidence was illustrated by the following participants.
It's great that someone getting a T-award can be placed on a clinician-scientist path. But if your T-award lapses and you don't get the [next level of] Clinician-Scientist Award, does that mean that you come off the career path and go back again to full time clinical work? Then once you go back to full time clinical work, not only your research thinking will suffer tremendously but you also won't be able to fund your own research team. (Participant 3)
After your research stops, they may throw you back to do all the rest of the clinical work, which you have been out of touch for the last five to ten years, and you will struggle. The more you give up, the more difficult it will be for you to come back later on. (Participant 1) Participants consistently maintained that 3-year funding duration of the T-award was insufficient to get the research project up and running, analyse and write manuscripts accepted in high impact journals and plan a strategic research agenda for further research funding application. This created a sense of insecurity in their future career paths. Indeed, approximately one in four participants (24%) expressed uncertainty about pursuing a research career (table 1).
As a new junior investigator, you need to set up a new lab. But you have a lot of pressure to publish high impact factor papers at the end of the term that is obviously less than three years…It is something that is difficult to meet for a lot of people because it takes time to get their research off the ground. It took me close to two years to actually get the animals in, get the experiments going, and get the data generated. (Participant 20)
I got my T-award at the end of last year. I feel like once you got it, the clock is ticking. Then you haven't started but you already feel it's like a tightened schedule to finish and to gain enough record to build up for the next step. (Participant 24) having the right skills and mindset to achieve work-life balance Participants commonly acknowledged the importance of family support in research career success. In particular, they viewed family support as being instrumental to managing the substantial demands from both clinical and research workloads.
A critical component is support from family because if I work till late at night having to stay back at the hospital, someone has to look after my son. Without support from my family I wouldn't have reached this far actually. There's just simply no way, no matter how family-oriented the institution can claim to be.
(Participant 15)
Notably, competing expectations of career and personal/family life were not viewed as something to lament, let alone conceptualised as a factor impeding one's research productivity and career progression. Rather, it was a representation of how one approached the challenges associated with work-life issues. As the following quotes illustrate, many participants made sense of the balance between personal commitments and work as a matter of developing resilience and skill sets and displayed a personal coping strategy to negotiate the reality.
If you didn't have the basic skill sets of managing your family and your stuff, I don't think you're going to get This indicates that certain sacrifices in personal/family life are necessary to become successful clinician-scientists. While few female participants, when elicited, expressed the challenges of having to respond to the demands of both work and family commitments, no marked difference in the attitude towards work-life balance was observed between men and women in this study.
DIsCussIOn
This study provided unique descriptions of the ways in which early career clinician-scientists experienced and managed the career transition in the context of emerging Asian AMCs. To our knowledge, this is the first national study to comprehensively examine the current experiences and perceptions of clinician-scientists towards pursuing a research career in Asia. In addition to the observations found in previous studies, our findings revealed important insights into the specific limitations presented by the current academic and research environment in Asia.
Our findings resonated with those reported by other researchers that clinical priorities represented an overarching concern and the main cause for a diminishing motivation for pursuing a research career. 6 8 11 12 31-34 Many participants reported difficulty delineating responsibilities related to clinical care and research, resulting in insufficient protected time to be successful in research endeavours. Research suggests that protected time for research is critical to career satisfaction and clinician's research productivity. 8 32 33 This indicated a need for support for clinician-scientists to secure dedicated research time. At the same time, what emerged salient from the account of participants was that there appeared to be a widespread climate among the local institutions in which research pursuit was little valued. This was manifested in a range of areas: being unsympathetic to the need for research and role of clinician-scientists at the institutional level; slower promotion than clinical peers in the same specialty with reduced remuneration and poor administrative and logistical support for research-related activities. The fundamental issue therefore is not merely a matter of securing protected time for research in our setting. Rather, it is the cultural and institutional elements inherent in the existing system that prioritises clinical work over research and that consequently serves to constrain those committed to a research career path. The interplay between institutional inertia and drivers for change in academic medicine underlines that tackling institutional culture will require systemic actions that are further reaching and more difficult than advising early career clinician-scientists on how to navigate institutional challenges. Although a large-scale change may be daunting, an overarching strategy involving key stakeholders to increase the perceived value of clinician-scientists should be implemented.
Our study found that despite the recognised importance of mentorship in career success and satisfaction in academic medicine, 6 8-10 14 32 35 few participants received appropriate mentoring across the trajectory of the T-award. Participants perceived diverse mentoring needs, but recognised the difficulty in having a mentor with different skill sets and functions. International mentors were often sought by some T-award recipients to address unique needs when receiving inadequate support from mentors from within their own institutions. Notably, our participants tended to identify mentors through their own efforts in a relatively haphazard manner rather than seek a more personalised and comprehensive mentorship. A variety of factors may have contributed to this but a dearth of role models and inadequate reward systems for mentoring may have resulted in the aforementioned haphazard manner of selecting mentors. Consequently, the value of using mentors for help was primarily driven by interim and temporary considerations such as having a mentor endorse the T-award application, securing protected time for research from clinical duties and using mentor's laboratory space. It became apparent that even for those who managed ongoing interaction with mentors, support from mentors was found to be limited in terms of targeted scientific guidance and long-term commitments to the relationship. This is in contrast to the situation in established AMCs in North America, 17 19 21 where there is a shared value and alignment of research projects between mentor and mentee and hence mentorship does evolve and grow as the mentees move towards independence. Our findings suggest a growing need for a structured mentoring model to systematically support mentees' individual needs and preferences as well as to publicly recognise mentoring efforts. Given a relatively small pool of senior mentors readily available in our setting, this model may further benefit from what other researchers have described as the '360° mentoring network', 18 which is a network that represents different types of mentors based on competencies with varying career stages and status levels.
Another key finding of the current study is that we did not observe prevailing perceptions of work-life incompatibility in academic medicine, which is in stark contrast to the prior studies conducted elsewhere. 8 12 22 36 While participants often acknowledged the importance of family support for their careers, the work-life balance by itself was neither generally conceptualised as a 'barrier' to the successful pursuit of a research career nor was it translated into the reasons for leaving the dual clinical-research career pathway. Also, there was no distinct difference in the perception of work-life balance by gender. What is noteworthy and potentially intriguing is that many saw certain individual qualities such as tenacity, hard work and appropriate skill sets as something that could overcome challenges associated with personal-professional commitments. Research suggests that contrary to Western culture in which the self-value is relatively emphasised, Asian culture is largely influenced by collectivism that emphasises developing and maintaining harmony within family and group. 37 As a result, in Asian culture, information is communicated in a polite, indirect and restrained manner so as to protect personal relationship from public embarrassment. It could be the case that our participants were sensitive to issues associated with family and personal circumstances and hence felt reticent to express their views in an explicit and direct manner. 38 It is also possible that the primary value of perseverance in achieving one's goal in Asian culture may have influenced how our participants approached the issue of work-life balance. 37 The ways in which early career clinician-scientists perceived and dealt with work-life balance in Asian culture may provide further avenues for examining cross-cultural variations in the management of personal-professional commitments in academic medicine.
Our study also provides strong evidence to support previous research that early career clinician-scientists experience mounting pressures to secure the next level of funding with diminishing confidence and time commitments. 6 8 39 40 The funding duration of the T-award (ie, 3 years) was thought to be insufficient to finish the research project and amass needed publications to be competitive for independent funding. Compared with the counterparts in established AMCs in North America, 8-10 17 21 maintaining continued grant funding was further challenged for our participants by the absence of supportive mentoring relationship and institutional resources that were pivotal in enabling them to remain dedicated to research in the event of career adversity or gap years by providing continued access to shared staff, supplies and other resources. The perceived difficulty in securing independent funding and the possibility of having to 'drop out' of research career placed tremendous pressure on early career clinician-scientists and led to a sense of uncertainty and vulnerability in the academic medicine career path. 41 42 Our findings suggest the need for sustained funding 7 to enable promising investigators to continue to pursue their productive research endeavours. However, simply providing more funding may be neither sufficient nor feasible. To provide a clearly defined and viable career path for clinician-scientists, AMCs have to adopt effective tools to track their career development and innovate solutions to address the enduring cacophony between clinical duties and research interests.
Findings from this study should be considered in light of several limitations. While we recruited a diverse range of participants in terms of gender, age and clinical rank in order to garner different opinions concerning the early career development, it was not possible to explore in depth the views of certain groups. For example, we did not provide a gender-specific account of career challenges although no distinct gender difference 43 was observed. Additionally, while the focus group enabled us to observe social interactions and group dynamics, individuals in the group might have influenced comments and thus some participants might have felt intimidated in sharing personal experiences. We limited our participants to practicing clinicians with developing research interest for a dual-career path and therefore our results may not be applicable to individuals with non-clinical background seeking careers in academic medicine or clinically trained scientists who only do research. We are unable to claim that the findings of this investigation based on a single country study are wholly generalisable to other emerging Asian academic medical settings. Despite these limitations, we hope that this study may provide useful information for other settings that embark on fostering a clinician-scientist workforce.
In conclusion, this study sheds light on the challenges and opportunities that early stage clinician-scientists faced in the context of emerging Asian AMCs. Our study is timely in the current environment of efforts to develop a vibrant clinician-scientist workforce in Asia with an aim to build a robust and globally competitive biomedical research infrastructure. 44 To retain this nascent clinician-scientist workforce, measures required include improving institutional culture of research, building mentoring networks, adopting effective tools for tracking career progress and providing a clear and viable career progression path for clinician-scientist. More broadly, it would be imperative to enhance societal awareness that supporting the success of clinician-scientists is not simply an investment in biomedical advances, but in the future of the nation's health and healthcare delivery as well.
